HBM Healthcare Investments (Cayman) Ltd., 10% Owner at Nabriva Therapeutics plc (NBRV), sold 67,676 shares at $10.50 ($711K) on 2017-07-19, disclosed to the SEC on 2017-07-24.
Open-market sale of $711k NBRV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.50 | 20,786 | $218K | 30.7% |
| 2 | $10.50 | 23,445 | $246K | 34.6% |
| 3 | $10.50 | 23,445 | $246K | 34.6% |
| Total | $10.50 avg | 67,676 | $711K | 100% |
| Filing → |
| NBRV | SELL | 2017-09-14 | $598K | — | Filing → |
| NBRV | SELL | 2017-09-05 | $6K | — | Filing → |
| NBRV | SELL | 2017-08-09 | $208K | — | Filing → |